Pharma courses

pharma courses


Ranjitha B1, Dinesh Bhaskar1, Balasubramanian Sathyamurthy2
1 Department of Biochemistry,
Reva Institute of Science and Management, Bangalore, Karnataka, India
2 Department of Biochemistry,
Ramaiah College of Arts, Science and Commerce, Bangalore,
Karnataka, India

The leaves of Terminalia Arjuna are commonly known as Arjuna. It is used as traditional medicinal plant distributed throughout the greater part of the Indian Peninsula along rivers and found in Sub-Himalayan tract, Chota Nagpur, Orissa, West Bengal, Punjab, Deccan and Konkan it has many medicinal properties like anti bacteria, anti inflammatory and used for the treatment of Asthama, Bronchities. These leaf extracts are found to have antioxidant, anticancer and antidiabetic activities. Out of many constituents arjunolic acid is the active principle which is responsible for antidiabetic effects. The present work was aimed to study the effect of Terminalia arjuna. Methanolic extracts on adipocyte 3T3-L1cell line and found the phytochemical compounds of Terminalia arjunaleaves have more inhibitory scavenging and more antidiabetic activities

Reference Id: PHARMATUTOR-ART-2600

PharmaTutor (Print-ISSN: 2394 - 6679; e-ISSN: 2347 - 7881)

Volume 6, Issue 8

Received On: 27/06/2018; Accepted On: 10/07/2018; Published On: 01/08/2018

How to cite this article: Sathyamurthy, B., Ranjitha, B. and Bhaskar, D. 2018. Invitro studies on the effect of Terminalia Arjuna in Adipocyte 3T3 - L1 Cell Lines. PharmaTutor. 6, 8 (Aug. 2018), 17-26. DOI:

Human beings and their ancestors have always been affected by diseases. Even as early as 5,000 years ago, human beings were aware of the medicinal properties of plants and observed that a number of important modern pharmaceuticals have been derived from, or are plants used by indigenous people. The advent of modern allopathic and ayurvedic medicine turned attention of scientists increasingly from plant sources to synthetic preparations as the basis for modern drugs. However, the side-effects of many modern drugs along with the development of drug-resistant organisms have brought back into focus ethnomedicinal studies (Kumar et al., 2002).
Diabetes mellitus is a major endocrine disorder affecting more than 10% population in the contemporary world. India has the dubious distinction of having the largest number of people with diabetes. Its occurrence in more affluent societies is spectacular and of general concern

Diabetes mellitus (DM) is a common and epidemic disease affecting the people of both the developed and developing countries. DM is caused by the abnormality or dysfunction of carbohydrate metabolism. The food we eat is broken into simple sugar called glucose. Glucose is the main source to get energy for the body. After digestion, it reaches our blood stream and the body cells utilize it for energy. Insulin is very essential for the glucose uptake into the cells. Insulin is a hormone secreted by the pancreas. If the pancreas does not produce enough insulin, glucose get into the body cells so, glucose stays in the blood. This makes the blood as hyperglycemic condition and symptoms include Fatigue or severe weakness, abnormal thirst, Irritability, Unexplained weight loss, increased hunger, recurrent infections, blurred vision, increased urination and nocturia. In normal individuals, the liver acts a storehouse of carbohydrates and releases glucose whenever the need arises. The pancreas produces insulin, which circulates in the blood and allows the entry of sugar in the cells. It also helps lowering the blood sugar levels. In case of prediabetic patients, the pancreas does not produce enough insulin leading to increased levels of sugar in the blood up to 100-125 mg/dl. Nowadays, Diabetes is ‘killer’ of mankind when compared to the disease like cancer and cardiovascular disease. In India, the number of adults suffering from diabetes is expected to increase in threefold from 19.4 million in 1995 to 57.2 million in 2025. The three main important classical symptoms of diabetic conditions are, polyuria (frequent urination), polydipsia (increased thirst), and polyphagia (increased hunger). Diabetes may be categorized into many types but the two major types are type 1 and type 2. On the basis of etiology, the term type 1 and type 2 were widely used to describe IDDM and NIDDM, respectively; other specific types of diabetes and gestational diabetes (Green et al., 1976).

On the basis of etiology, type 1 diabetes is present in patients who have little or absence of endogenous insulin secretory capacity and who therefore require insulin therapy for survival. The two main forms of clinical type 1 diabetes are type 1a which is thought to be due to immunological destruction of pancreatic ß cells resulting in insulin deficiency; and type 1b (idiopathic, about 10% of type 1 diabetes), in which there is no evidence of autoimmunity. Type 1a is characterized by the presence of islet cell antibody (ICA), anti-glutamic acid decarboxylate (anti-GAD), IA-2 or insulin antibodies that identify the autoimmune process with ß-cell destruction. Autoimmune diseases like Grave’s disease, Hashimoto’s thyroiditis and Addison’s disease may be associated with type 1 diabetes mellitus. There is no known etiological basis for type 1b diabetes mellitus. Some of these patients have permanent insulinopaenia and are prone to ketoacidosis, but have no evidence of autoimmunity. This form is more prevalent among individuals of African and Asian Origin. Type2 diabetes also called non-insulin-dependent diabetes mellitus (NIDDM). Type 2 diabetes may account for about 80 percent to 90 percent of all diagnosed cases of diabetes. Risk factors may include older age, obesity, family history of diabetes, gestational diabetes, impaired glucose tolerance, physical inactivity, and race.

Gestational Diabetes (GD) mellitus refers to the onset or initial recognition of glucose intolerance during pregnancy, usually in the second or third trimester. It occurs in about 4% of all pregnancies. Patients with GD have a 30% to 50% chance of developing DM, usually type 2 DM (Kumar et al., 2002).

3T3-L1 Mouse Cell Line:
Organism : Murine Swiss (mouse)
Tissue : Adipocyte
Disease : Related to obesity
Age : 19 Days old embryo
Gender :Female
Morphology : Fibroblast
Growth Properties : Adherent

The 3T3-L1 cell line is a preadipose cell line that was developed from murine Swiss 3T3 cells. The 3T3-L1 cells are derived from disaggregated 17- to 19-day-old Swiss 3T3mouse embryos, which display a fibroblast-like morphology that, under appropriate conditions, can acquire an adipocyte – like phenotype. Indeed, close to a third of the published articles in the last five years have described the use of 3T3-L1 cells for the study of adipogenesis and obesity-related characteristics (Green et al., 1976). Generally 3T3-L1 fibroblast phenotype cells wear treat with adipogenic agents, such as insulin, dexamethasone (DEX), and 3-isobutyl-1-methylxanthine (IBMX), to convert to adipocytes, it is necessary to which elevates the intracellular cAMP levels in the presence of fetal bovine serum (FBS), at concentrations of 1µg/ml, 0.25 µM, and 0.5 mM, respectively. 3T3-L1 cells can be differentiating within 10 to 12 days. Differentiation of 3T3-L1 preadipocytes can be influenced in a short time using a combination of DEX and troglitazone after few days compared to the combination of IBMX and DEX with the standard protocol. Moreover, by using DEX and troglitazone, the lipid droplet accumulation increased by 112%, and glucose transporter 4 (GLUT4) mediated a 137% higher glucose uptake compared to cells that were differentiated using the traditional method (Vishwanath et al., 2013)

One of the main advantages of this cell line is that it is easier to culture and less costly to use than freshly isolated cells, such as mature adipocytes, even though freshly isolated cells allow for various comparisons, such as the in vitro evaluation of different in vivo conditions. Moreover, they can tolerate an increased number of passages and are homogeneous in terms of the cell population. Therefore, these cells provide a homogenous response following treatments and changes in experimental conditions (Poulos et al., 2010). Because of this, 3T3-L1 cells have been extensively over the last five years to evaluate the effects of compounds or nutrients on adipogenesis, to establish the underlying molecular mechanisms of adipogenesis and to evaluate the potential application of various compounds and nutrients in the treatment of obesity. Particularly, compounds such as quercetin and resveratrol inhibit adipogenesis in 3T3-L1 adipocytes and also these cells have been used to describe the effect of melatonin, reactive oxygen species (ROS), or antioxidants on adipogenic differentiation and also, the role of some androgens such as testosterone that inhibit the adipogenic differentiation by activation of androgen receptor/β-catenin/T-cell factor 4 interaction in 3T3-L1 adipocytes. Apart from that, 3T3-L1 cells have been useful to study the mechanisms of action during the differentiation process of several compounds or nutrients (Chang et al., 2016). Finally, this cell line is useful in the study of co-cultures and three-dimensional cell cultures, as well as diverse studies of high-throughput screening of compounds. The 3T3-L1 model has several drawback such as the time of initial subculture, in addition to the fact that adipogenic differentiation requires at least 15 days. Moreover, when 3T3-L1 cells become confluent or they have been passaged extensively, they no longer differentiate into adipocytes; they are difficult to transfect; and because this cell line originated from a single clone,it fails to recapitulate the characteristics of primary cell culture models (Francisco Javier Ruiz-Ojeda et al., 2016).

Terminalia arjuna:
Terminalia Arjuna  commonly known as Arjuna, Nearly 24 species of Terminalia have been reported from various parts of India and it is large evergreen tree distributed throughout the  Indian Peninsula along rivers and found in Sub-Himalayan tract, Nagpur, Orissa, West Bengal, Punjab, Deccan and Konkan (Padmaa et al., 2010). The tree is about 60-80 feet height. Arjuna is large, evergreen with a spreading crown and dropping branches. In favorable localities and especially along the banks of streams, the tree attains very large sizes. Two trees of 26 feet and 32 feet in girth at 5 feet from the ground have been recorded in the village of Manipur in Jammu and Kashmir. Leaves are sub-opposite, oblong or elliptic, coriaceous, cordate, shortly acute or obtuse at the apex. Flowers are in panicled spikes. Fruits are ovoid or ovoid-oblong, 2.5 – 5.0 cm long, nearly glabrous, with 5 – 7 hard, winged angles. Stem bark is simple, grey and smooth on external surface. It is big, soft and of red color from inside and bitter in taste. Leaves are like oblong and 4-6 inch long and 2-3 inch wide, sub opposite, glabrous and often in equilateral. Two glands are present near the base of the petiole. The margin is crenulate with apex at obtuse or sub acute angle. The base is rounded or cordate. Petioles run for 0.5 to1.3 cm. Flowers are White or yellowish and found in groups. Flowering occurs in summer and fruit appears in winter or spring season. The fruits are 1 - 1.5 inch in diameter, with 5-7 longitudinal lobes. These are glabrous with 5-7 wings, woody and fibrous. Fruit is drupe and often notched near the top, marked with oblique upward curving striations (Sumitra et al., 2001). Chemical composition of the bark contains calcium carbonate 34%, other calcium salts 9% and tannin 16%. Besides, it also contains aluminium, magnesium, organic acid, colouring matter and sugar. Other active constituents of Terminalia Arjuna include arjunic acid, arjunolic acid, arjungenin, and arjunglycosides. arjunone, arjunolone, and luteolin, Gallic acid, ellagic acid, oligomeric proanthocyanidins (OPCs), phytosterols, zinc, and copper (Giri et al., 2012).

Role of Arjunolic Acid in diabetes:
Two enzymes, α-glucosidase and α-amylase, play a pivotal role (mainly in type 2 diabetes) in the reduction of excess dietary carbohydrate and formation of glucose from those molecules. Therefore, inhibition of these two enzymes could be helpful in the treatment of diabetic pathophysiology and its associated complications. In the case of two antioxidant molecules (curcumin and mangiferin), reported significant inhibitory action against these two carbohydrate-metabolizing enzymes whereas AA is not able to do so to a considerable extent. It has been reported that AA obtained from the leaves of Lagerstroemia speciosa attenuates the α-glucosidase to some extent but possesses insignificant inhibitory activity against α-amylase. Though this antioxidant molecule is unable to suppress the activity of mentioned two enzymes, a number of research studies suggest its protective action in diabetes. It can be depicted that the antidiabetic action of this component is attributed to its antioxidant activity (Khaliq et al., 2013). Protective role of amino acid on pancreatic tissue in STZ-induced type 1 diabetic rat model was described that, the intoxication of STZ leads to the formation of reactive oxygen and nitrogen species in the β-cell containing pancreatic tissue of the experimental group. Formation of excessive reactive species overwhelmed the intracellular antioxidant defense system and enhanced the peroxidation of membrane lipids as well as carbonylation of different proteins. Increased serum glucose and proinflammatory cytokine TNF-α were also found in the STZ-administered group. However, treatment with AA is able to ameliorate the condition by the efficient scavenging of free reactive species and reducing the expression of stress-induced MAPKs (phospho ERK1/2 and phospho p38), transcription factor NF-κB and regulating the molecules involved in mitochondrial-dependent apoptotic pathways (Manna et al., 2008). This group also demonstrated the efficacy of AA against STZ-induced spleen damage under hyperglycemic state. Most of the primary immune responses are initiated in the spleen and cytokine production by spleen cells is probably considered as one of the reasons for the β-cell destruction in type 1 diabetes. AA has been found to regulate the expression of different cytokines (IL-2, IFN-γ, and TNF-α) and maintain intracellular redox environment to protect spleen from oxidative stress-induced inflammatory response-mediated damage. In addition, the histopathological study showed that AA ameliorates splenic white pulp (responsible for immunological function) and decreased red pulp to enhance the immune response in type 1 diabetes (Wang et al., 2007). Efficacy of AA against STZ-induced diabetic nephropathy was shown that the diabetic renal damage is associated with increased kidney weight to body weight ratio, glomerular area and volume, blood glucose level, serum creatinine level, and BUN. Alteration in kidney-related and other parameters indicates renal dysfunction that in turn increases the generation of reactive species, enhances oxidative stress-related markers, and reduces intracellular antioxidant defense in the renal tissue of diabetic group. Treatment with AA successfully ameliorates diabetes-induced oxidative stress-mediated renal damage by reducing oxidative as well as nitrosative stress and deactivating the polyol pathways of the kidney. The histological pattern showed multiple foci of hemorrhagic necrosis and cloudy swelling of tubules in the diabetic renal tissue. On treatment with AA amelioration of histopathological state was observed. This result suggests that AA could act as a protective agent against the renal oxidative stress-induced damage in diabetes (Manna et al., 2007)



Subscribe to Pharmatutor Alerts by Email